Gilead Sciences acquisitions: every deal in 2026
The mergers, acquisitions and takeovers Gilead Sciences has announced, agreed or completed in 2026, newest first, each with its value, status and sources.
3Deals tracked
$12.6bnDisclosed value
$7.8bnLargest deal
3Completed
Gilead Sciences acquisitions: every deal in 2026
- 7 Apr 2026Gilead agrees up to US$5bn deal for TubulisGilead Sciences, Inc. → Tubulis GmbHHealthcare / BiotechCompleted$3.2bn
- 23 Mar 2026Gilead agrees US$1.7bn deal for Ouro MedicinesGilead Sciences, Inc. → Ouro MedicinesHealthcare / BiotechCompleted$1.7bn
- 23 Feb 2026Gilead agrees US$7.8bn deal for ArcellxGilead Sciences, Inc. → Arcellx, Inc.Healthcare / BiotechCompleted$7.8bn